NCT02271529View on ClinicalTrials.gov

Zilver PTX Delivery System

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Peripheral Vascular Disease
Interventions
DEVICE

Zilver® PTX® Drug-Eluting Peripheral Stent

Treatment of symptomatic vascular disease of the native above-the-knee femoropopliteal arteries.

Trial Locations (6)

1023

Auckland City Hospital, Auckland

3248

Waikato Hospital, Hamilton

Wellington Hospital, Wellington

Vic 3199

Frankston Hospital, Frankston

Qld 4102

Princess Alexandra Hospital, Woolloongabba

D-79189

Universitäts-Herzzentrum Freiburg - Bad Krozingen GmbH, Bad Krozingen

All Listed Sponsors
lead

Cook Group Incorporated

INDUSTRY

NCT02271529 - Zilver PTX Delivery System | Biotech Hunter | Biotech Hunter